6576 |
北城證券研發部提供 非經同意不得轉載 本刊內容僅供參考 投資人應謹慎考量投資風險 本公司不負任何法律責任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6576 逸達 |
實收資本額 |
1548 (百萬) |
|
|
|
|
|
|
|
|
|
市 場
別 |
OTC |
上 櫃 日 期 |
2018/06/29 |
|
|
|
|
|
|
|
|
|
發 言
人 |
詹孟恭 |
電 話 |
(02)77500188 |
|
|
|
|
|
|
|
|
|
地 址 |
台北市南港區三重路19-3號9樓之2 |
|
|
|
|
|
|
|
|
|
產 業
別 |
傳產-生技 |
|
|
|
|
|
|
|
|
|
主要產品 |
銷貨收入70.1%、權利金收入28.6%、勞務收入1.3%(新藥研發) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/5/2 股價 |
67.80 |
法人買賣超合計(近一日) |
賣超 -4.23 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌 |
0.30
|
法人買賣超合計(近一週) |
買超
62.67 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌幅 |
0.44
|
法人買賣超合計(近一月) |
買超
25.5 張 |
|
|
|
|
|
|
|
|
|
券 資 比 |
|
外資連2賣 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
最新股利發放 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
殖利率 |
|
|
|
|
|
|
|
2023/06/01 |
#N/A |
#N/A |
#N/A |
#N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
股利年度 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
扣抵率(%) |
殖利率 |
股利殖利率 |
現金殖利率 |
|
|
|
|
2024 |
2025/05/29 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2023 |
2024/06/24 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2022 |
2023/06/01 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2021 |
2022/06/29 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
機構估稅後EPS |
-5.16 |
K(9) |
83.59 |
|
技術面 |
技術面 |
基本面 |
基本面 |
籌碼面 |
|
|
|
|
淨值(元) |
10.33 |
D(9) |
75.76 |
評分表 |
(短線) |
(中長線) |
(安全性) |
(成長性) |
|
|
|
|
預估本益比 |
-13.14 |
周K(9) |
34.73 |
|
1.6 |
1.2 |
0.8 |
1.2 |
1 |
|
|
|
|
股價淨值比 |
6.56 |
周D(9) |
42.32 |
綜合評分: |
5.8 |
建議: |
觀望 |
目標價: |
64.77 |
|
|
|
|
月線乖離率 |
3.26 |
季線乖離率 |
-12.57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/4/2 |
2025/4/11 |
2025/4/18 |
2025/4/25 |
2025/5/2 |
20*PE |
|
3*PB |
40.12 |
|
|
|
|
股價 |
79.10 |
64.40 |
64.40 |
65.60 |
67.80 |
15*PE |
|
2*PB |
26.75 |
|
|
|
|
成交量(千股) |
382 |
1,547 |
805 |
331 |
659 |
10*PE |
|
1*PB |
13.37 |
|
|
|
|
資餘 |
|
|
|
|
|
5*PE |
|
0.5*PB |
6.69 |
|
|
|
|
券餘 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
季IFRS財報(損益單季) |
202501 |
202404 |
202403 |
202402 |
202401 |
202304 |
202303 |
202302 |
|
|
|
|
營業收入淨額(千) |
|
140,547
|
80,103
|
94,183
|
103,856
|
68,422
|
60,723
|
37,487
|
|
|
|
|
營業成本(千) |
|
18,789
|
46,486
|
50,746
|
62,867
|
32,310
|
17,728
|
2,818
|
|
|
|
|
營業毛利(千) |
|
121,758
|
33,617
|
43,437
|
40,989
|
36,112
|
42,995
|
34,669
|
|
|
|
|
營業費用(千) |
|
609,850
|
326,317
|
207,755
|
175,669
|
354,520
|
284,771
|
308,228
|
|
|
|
|
營業利益(千) |
|
-488,092 |
-292,700 |
-164,318 |
-134,680 |
-318,408 |
-241,776 |
-273,559 |
|
|
|
|
營業外收入及支出(千) |
|
9,990
|
-1,626 |
11,401
|
26,822
|
-12,322 |
25,938
|
4,397
|
|
|
|
|
稅前純益(千) |
|
-478,102 |
-294,326 |
-152,917 |
-107,858 |
-330,730 |
-215,838 |
-269,162 |
|
|
|
|
所得稅(千) |
|
10,807
|
13,957
|
11,417
|
11,688
|
7,830
|
20,718
|
12,775
|
|
|
|
|
稅後純益(千) |
|
-488,909 |
-308,283 |
-164,334 |
-119,546 |
-338,560 |
-236,556 |
-281,937 |
|
|
|
|
其他綜合損益(千) |
|
3,440
|
-5,500 |
4,781
|
5,387
|
-6,038 |
4,289
|
2,637
|
|
|
|
|
綜合損益(千) |
|
-485,469 |
-313,783 |
-159,553 |
-114,159 |
-344,598 |
-232,267 |
-279,300 |
|
|
|
|
原始每股稅前盈餘(元) |
|
-3.09 |
-2.15 |
-1.12 |
-0.79 |
-2.44 |
-1.59 |
-1.98 |
|
|
|
|
原始每股稅後盈餘(元) |
|
-3.16 |
-2.25 |
-1.21 |
-0.88 |
-2.49 |
-1.74 |
-2.08 |
|
|
|
|
毛利率(%) |
|
86.63
|
41.97
|
46.12
|
39.47
|
52.78
|
70.81
|
92.48
|
|
|
|
|
營業利益率(%) |
|
-347.28 |
-365.40 |
-174.47 |
-129.68 |
-465.36 |
-398.16 |
-729.74 |
|
|
|
|
稅後純益率(%) |
|
-347.86 |
-384.86 |
-174.48 |
-115.11 |
-494.81 |
-389.57 |
-752.09 |
|
|
|
|
稅後權益報酬率(%) |
|
-42.46 |
-36.18 |
-15.29 |
-9.99 |
-24.02 |
-14.04 |
-22.19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
月營收 |
單月營收(千) |
累計營收(千) |
單月MoM |
單月YoY |
累計YoY |
累計稅前EPS |
備註 |
近3月營收(千) |
近3月年成長 |
|
|
|
|
202504 |
0 |
0 |
0.00
|
0.00
|
0.00
|
|
|
0 |
0 |
|
|
|
|
202503 |
28,377 |
110,462 |
-60.00 |
-33.21 |
6.36
|
|
|
110,462
|
6.36 |
|
|
|
|
202502 |
70,946 |
82,085 |
536.92
|
148.30
|
33.76
|
|
|
97,178
|
7.82 |
|
|
|
|
202501 |
11,139 |
11,139 |
-26.20 |
-66.04 |
-66.04 |
|
|
35,879
|
-59.46 |
|
|
|
|
202412 |
15,093 |
418,689 |
56.45
|
-47.52 |
114.67
|
-6.67 |
|
140,548
|
105.41 |
|
|
|
|
202411 |
9,647 |
403,596 |
-91.67 |
-64.19 |
142.73
|
|
創近一年新低 |
150,717
|
50.21 |
|
|
|
|
202410 |
115,808 |
393,949 |
358.43
|
810.23
|
182.73
|
|
創近一年新高 |
160,207
|
118.26 |
|
|
|
|
202409 |
25,262 |
278,142 |
32.01
|
-58.37 |
119.67
|
-3.59 |
|
80,102
|
31.91 |
|
|
|
|
202408 |
19,137 |
252,879 |
-46.40 |
0.00
|
283.52
|
|
|
86,586
|
132.43 |
|
|
|
|
202407 |
35,703 |
233,742 |
12.46
|
82930.23
|
254.50
|
|
|
80,020
|
113.94 |
|
|
|
|
202406 |
31,746 |
198,039 |
152.53
|
-14.68 |
200.55
|
-1.68 |
|
94,183
|
151.24 |
|
|
|
|
202405 |
12,571 |
166,293 |
-74.79 |
8280.67
|
479.76
|
|
|
104,924
|
1411.22 |
|
|
|
|
202404 |
49,866 |
153,722 |
17.37
|
39164.57
|
438.75
|
|
|
120,926
|
1627.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
|
|
|
|
5850 |
統一 |
13 |
13 |
0 |
5920 |
元富 |
-4 |
0 |
4 |
|
|
|
|
5380 |
第一金 |
3 |
3 |
0 |
9800 |
元大 |
-3 |
5 |
8 |
|
|
|
|
8840 |
玉山 |
2 |
3 |
1 |
7000 |
兆豐 |
-2 |
2 |
4 |
|
|
|
|
8880 |
國泰 |
1 |
1 |
0 |
1650 |
新加坡商瑞銀 |
-2 |
0 |
2 |
|
|
|
|
8380 |
安泰 |
0 |
1 |
1 |
1480 |
美商高盛 |
-1 |
0 |
1 |
|
|
|
|
8450 |
康和 |
0 |
1 |
1 |
7790 |
國票 |
-1 |
0 |
1 |
|
|
|
|
8560 |
新光 |
0 |
0 |
0 |
8150 |
台新 |
-1 |
0 |
1 |
|
|
|
|
1040 |
臺銀證券 |
0 |
0 |
0 |
9A00 |
永豐金 |
-1 |
0 |
1 |
|
|
|
|
1260 |
宏遠 |
0 |
0 |
0 |
9100 |
群益金鼎 |
-1 |
0 |
1 |
|
|
|
|
1440 |
美林 |
0 |
0 |
0 |
9200 |
凱基 |
-1 |
0 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20250321 |
3月21日重要財經行事曆 |
|
|
|
|
20250311 |
逸達營收/2月7,095萬元創同期新高 月增537%、年增148% |
|
|
|
|
20250210 |
逸達前列腺癌新藥 跨步 |
|
|
|
|
20241206 |
逸達營收/前十一月4億元、年增1.4倍 明年將完成新藥國際授權 |
|
|
|
|
20241128 |
逸達新癌藥賣向英國 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股TOP15買賣超券商籌碼統計(20日) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1日籌碼集中度 |
3.1 |
|
10日籌碼集中度 |
9.9 |
|
單日買賣超 |
1 |
|
|
|
5日籌碼集中度 |
3.9 |
|
20日籌碼集中度 |
-2.5 |
|
累計買賣超 |
-292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股借券統計(20日) |
千張大戶統計(20週) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
單日借賣張數 |
0 |
借券餘額 |
0 |
千張大戶戶數 |
18 |
大戶比例 |
47.77 |
|
|
|
|
|
|
|
|
|
|
|
|
更新日期: |
2025/5/2 18:09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|